Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.


TSXV:MIR - Post by User

Bullboard Posts
Comment by alfun47on Nov 22, 2008 1:16pm
253 Views
Post# 15603977

RE: beedope posts...

RE: beedope posts...Good point. At the end of October I also eed Dr Smith and few things he replied do put some blame on government.

He states "In Canada we have not yet been able to justify, through a business plan, the high costs of further approvals and clinical trials that would allow us to do multiple or addition testings"

He also states, relating to Canada, "health care groups and investors often site the failure of the first Health Canada approved HIV test. It was obviously not done properly and had to be withdrawn. It seems to be partly used as an excuse for inadequate public health care programs." I believe the test he was referring to were done by the company now known as Adaltis.

These comments were in response to my e-mail about why the multiple test could not be used by the government of Alberta, and now Saskatchewan, to test all those patients who may have been exposed to Hep and HIV through multiple use of needles in some hospitals. They are easy to use and give results in minutes.

Here we had a prefect opportunity, in Canada, to show the benefit of the products and they were not able to use them because of the cost and process for getting approval.

They are focussing on the US as a market with bigger potential, where they have had greater success.

By the way, if any of you know of any marketing and distrubition companies that want to become active in pushing these products in Canada, I beleive Medmir would be interested in hearing from them.

Alfun47
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse